4.5 Article

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Journal

FRONTIERS IN HUMAN NEUROSCIENCE
Volume 16, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnhum.2022.813387

Keywords

deep brain stimulation; artificial intelligence; neuroethics; pain; interventional psychiatry; adaptive DBS; epilepsy; traumatic brain injury

Funding

  1. NIH [R25NS108939, UH3 NS103549, UH3NS103550, 2R01MH102238, R01 NR014852, R01NS096008]
  2. McNair Foundation
  3. Dana Foundation
  4. Medtronic
  5. BRAIN Initiative
  6. National Institute of Neurological Disorders and Stroke
  7. James S. McDonnell Foundation
  8. Boston Scientific
  9. Michael J. Fox Foundation
  10. Hope for Depression Research Foundation
  11. Parkinson's Foundation
  12. Parkinson Alliance
  13. Smallwood Foundation
  14. BachmannStrauss Foundation
  15. Tourette Syndrome Association
  16. UF Foundation

Ask authors/readers for more resources

The DBS Think Tank IX conference provided an open platform for clinicians, engineers, and researchers to discuss DBS technologies and related issues. The consensus among the speakers was that DBS is expanding its scope and being applied to various brain disorders. Over 230,000 DBS devices have been implanted globally.
DBS Think Tank IX was held on August 25-27, 2021 in Orlando FL with US based participants largely in person and overseas participants joining by video conferencing technology. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers and researchers (from industry and academia) can freely discuss current and emerging deep brain stimulation (DBS) technologies as well as the logistical and ethical issues facing the field. The consensus among the DBS Think Tank IX speakers was that DBS expanded in its scope and has been applied to multiple brain disorders in an effort to modulate neural circuitry. After collectively sharing our experiences, it was estimated that globally more than 230,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. As such, this year's meeting was focused on advances in the following areas: neuromodulation in Europe, Asia and Australia; cutting-edge technologies, neuroethics, interventional psychiatry, adaptive DBS, neuromodulation for pain, network neuromodulation for epilepsy and neuromodulation for traumatic brain injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available